Metagenomi Therapeutics, Inc.

MGX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
34
SEC Filings

Business Summary

5 Item 1A. Risk Factors 34 Item 1B. Unresolved Staff Comments 97 Item 1C. Cybersecurity 98 Item 2. Properties 98 Item 3. Legal Proceedings 99 Item 4. Mine Safety Disclosures 99 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 100 Item 6. [Reserved] 100 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 101 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 111 Ite...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMGXdiscussed_in_filing Cybersecurity
topic_mentionMGXdiscussed_in_filing Cybersecurity
topic_mentionMGXdiscussed_in_filing Cybersecurity
topic_mentionMGXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-093976EDGAR111K words
2025-03-172024-12-310000950170-25-040217EDGAR—
2024-03-272023-12-310000950170-24-036838EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-276150EDGAR76K words
2025-08-122025-06-300000950170-25-107308EDGAR—
2025-05-132025-03-310000950170-25-070463EDGAR—
2024-11-132024-09-300000950170-24-126273EDGAR—
2024-08-142024-06-300000950170-24-096665EDGAR—
2024-05-142024-03-310000950170-24-059504EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-093943EDGAR2K words
2026-01-120001193125-26-009928EDGAR—
2025-11-120001193125-25-276135EDGAR—
2025-10-010001193125-25-226878EDGAR—
2025-08-120000950170-25-107304EDGAR—
2025-06-110000950170-25-084529EDGAR—
2025-05-140000950170-25-070906EDGAR—
2025-05-130000950170-25-070448EDGAR—
2025-03-170000950170-25-040453EDGAR—
2025-03-170000950170-25-040238EDGAR—

34 total filings indexed. 15 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001785279
TickerMGX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c6e6b60ac19afaa9385fe59d99ec3872db9bfbfd9d94318c8c7eb24230976645
parent: 014a7c3b1a9acd99552ae8c66da0c33b9489d10ae360d69b22a728c3bbf83267
content hash: aca0ed55da2f5917c1c5599e4971be1f652a4c252e592e876f9a93b04956960d
signed: 2026-04-13T04:46:15.522Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf